In an era where precision health tech approaches are transforming clinical practice, nephrology has evolved at an unprec...
Japan-headquartered Fujifilm Corporation's Life Sciences Group companies, a portfolio of businesses offering products, s...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development,...
Taxis Pharmaceuticals, a US-based clinical stage company at the forefront of developing therapies to treat multidrug-res...
Taiwan’s National Biotechnology Research Park (NBRP) hosted the 2025 Antibody Therapeutic & Frontiers in Biome...
XellSmart Biopharmaceutical (Suzhou/Shanghai) Co., Ltd. announced that the National Medical Product Administration (NM...
Researchers from the Critical Analytics for Manufacturing Personalized-Medicine (CAMP) and Antimicrobial ...
Alloy Therapeutics Inc., a US-based biotechnology ecosystem company, has recently opened its first location in Japa...
Rznomics Inc., a South Korea-based biopharmaceutical startup specialising in RNA-based therapeutics, has entered in...
Patients with non-proliferative diabetic retinopathy (NPDR) currently face a therapeutic gap—one that often leaves...
Agilent Technologies Inc. has signed a Memorandum of Understanding (MoU) with Ubix Therapeutics to accelerate highly tar...
Researchers at Korea Advanced Institute of Science and Technology (KAIST) have successfully developed a novel ...
The Heinz College of Information Systems and Public Policy, in the US, will work with the National University of Singapo...
The University of Queensland (UQ) in Australia will host a $238 million industry-led research centre to accelerate indus...
Sequential Skin Ltd, a world leader in skin microbiome testing, and AMILI, a leading expert in gut microbiome science, h...
The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, in partnership with P...
Singapore HSA has approved, Astellas Pharma Inc. VYLOY™ (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal...
ACRO Biomedical Co. has announced that its ABCcolla Collagen Ophthalmic Matrix has received regulatory ap...
